Fresenius Medical Care AG (FMS) EBIT (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported EBIT for 17 consecutive years, with $2.7 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, EBIT rose 38.51% year-over-year to $2.7 billion; the TTM figure through Dec 2025 stood at $4.2 billion (up 25.73% YoY), while the FY2025 annual figure was $2.1 billion, up 42.97% from the prior year.
• EBIT came in at $2.7 billion for Q4 2025 at Fresenius Medical Care AG, up from $557.1 million in the prior quarter.
• The five-year high for EBIT was $2.7 billion in Q4 2025, with the low at $280.1 million in Q1 2023.
• Average EBIT over 5 years is $711.2 million, with a median of $481.1 million recorded in 2025.
• Across the five-year window, EBIT sank 82.76% in 2021 and soared 434.18% in 2023, its largest moves.
• Year by year, EBIT stood at $513.6 million in 2021, then plunged by 30.08% to $359.1 million in 2022, then jumped by 434.18% to $1.9 billion in 2023, then increased by 0.1% to $1.9 billion in 2024, then surged by 38.51% to $2.7 billion in 2025.
• According to Business Quant data, EBIT over the past three periods registered $2.7 billion, $557.1 million, and $481.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.